Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1218 (LINC01218)
- Target
- LINC01218
- Molecular classification
- Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA), Other (Non-protein coding RNA)
01
Overview
Long intergenic non-protein coding RNA 1218 (LINC01218) is a human long intergenic non-coding RNA (lincRNA) gene. LincRNAs are defined as RNA transcripts longer than 200 nucleotides that do not overlap with protein-coding loci and generally do not encode proteins. LINC01218 is annotated as an autonomously transcribed locus with no reported protein product, sequence overlap with coding regions, or established molecular function. Like other lincRNAs, it may be involved in regulating gene expression and chromatin architecture, but there is no direct evidence in public resources or scientific literature for a distinct role of LINC01218 in disease or therapeutics. Its sequence and annotation are maintained in genomic databases (e.g., GeneCards, NCBI Gene), and its only known alias is EMCN-IT1.
- Other names
- EMCN-IT1
02
Mechanism of action
No known mechanism of action for drugs, since it is not an established drug target
03
Biological functions
Gene expression regulation (putative; function not experimentally established for LINC01218 specifically)Chromatin remodeling (general lincRNA function)Transcriptional regulation (general lincRNA function)RNA stabilization (general lincRNA function)
04
Disease associations
Other (no specific disease association directly linked; some lincRNAs are associated generally with cancer, but no clear evidence for LINC01218 specifically)
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 1218 (LINC01218).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1218 (LINC01218).